Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
D000596:Amino Acids / Q000494:pharmacology; D000598:Amino Acids, Cyclic; D000818:Animals; D001931:Brain Mapping; D002415:Cats; D003342:Corpus Striatum / Q000502:physiology*; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004594:Electrophysiology; D004983:Ethanolamines / Q000494:pharmacology; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006719:Homovanillic Acid / Q000032:analysis; D006892:Hydroxydopamines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009118:Muscimol / Q000494:pharmacology; D009433:Neural Inhibition; D009434:Neural Pathways / Q000502:physiology; D016627:Oxidopamine; D010852:Picrotoxin / Q000494:pharmacology; D051381:Rats; D013378:Substantia Nigra / Q000502:physiology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D000596:Amino Acids; D000598:Amino Acids, Cyclic; D003509:Cyclohexanecarboxylic Acids; D004298:Dopamine; D004983:Ethanolamines; D005968:Glutamate Decarboxylase; D006719:Homovanillic Acid; D006892:Hydroxydopamines; D009118:Muscimol; D016627:Oxidopamine; D010852:Picrotoxin; D005680:gamma-Aminobutyric Acid; C015666:3-aminocyclohexanecarboxylic acid; C020619:ethanolamine O-sulfate